Sauce https://www.justice.gov/criminal-fraud/file/1233011/download
Note: Excerpt starts on page 21 (of 99).
In addition to the Medicare Strike Force matters listed above, our respective Departments successfully pursued the following matters, which are grouped by subject below: Pharmaceutical and Device Manufacturers and Related Individuals
• In July 2012, GlaxoSmithKline paid $3 billion, plus interest, to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices. The company pled guilty and paid $1 billion in fines and forfeitures for misbranding the anti-depressant drugs Paxil and Wellbutrin and for failing to report required information to the Food and Drug Administration (FDA) in connection with the diabetes drug Avandia. GSK also paid $2 billion to resolve its FCA and civil liability for: (1) promoting the drugs Paxil, Wellbutrin, Advair, Lamictal and Zofran for off-label, non-covered uses and paying kickbacks to physicians to prescribe those drugs as well as the drugs Imitrex, Lotronex, Flovent and Valtrex; (2) making false and misleading statements concerning the safety of Avandia; and (3) reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program. As part of the settlement, GSK entered into a 5-year CIA (Corporate Integrity Agreement) with HHS/OIG.
My inner conspiracy theorist thinks the GlaxoSmithKline name is related somehow to Kevin KlineSmith. Haven't seen any connection, just the names stick out in a weird way i can't explain. Any hoo hope that sheds some truth on your search.
Sauce https://www.justice.gov/criminal-fraud/file/1233011/download
Note: Excerpt starts on page 21 (of 99).
In addition to the Medicare Strike Force matters listed above, our respective Departments successfully pursued the following matters, which are grouped by subject below: Pharmaceutical and Device Manufacturers and Related Individuals
• In July 2012, GlaxoSmithKline paid $3 billion, plus interest, to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices. The company pled guilty and paid $1 billion in fines and forfeitures for misbranding the anti-depressant drugs Paxil and Wellbutrin and for failing to report required information to the Food and Drug Administration (FDA) in connection with the diabetes drug Avandia. GSK also paid $2 billion to resolve its FCA and civil liability for: (1) promoting the drugs Paxil, Wellbutrin, Advair, Lamictal and Zofran for off-label, non-covered uses and paying kickbacks to physicians to prescribe those drugs as well as the drugs Imitrex, Lotronex, Flovent and Valtrex; (2) making false and misleading statements concerning the safety of Avandia; and (3) reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program. As part of the settlement, GSK entered into a 5-year CIA (Corporate Integrity Agreement) with HHS/OIG.